KAWASAKI-DISEASE - THE NORTHERN-IRELAND EXPERIENCE

被引：4

作者：

CASEY, F

CRAIG, B

SHANKS, D

JACKSON, P

MULHOLLAND, HC

机构：

[1] Department of Paediatric Cardiology, Royal Belfast Hospital for Sick Children, Belfast

[2] Infectious Diseases Unit, Belvoir Park Hospital, Belfast

来源：

IRISH JOURNAL OF MEDICAL SCIENCE | 1993年 / 162卷 / 10期

关键词：

D O I：

10.1007/BF02996316

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In the period 1985-1991 inclusive, forty rive cases of Kawasaki Disease were identified in Northern Ireland. The number of cases increased each year until 1988 when the incidence was 19 per million population under 16 years, the highest reported for any region in the United Kingdom (data from British Paediatric Surveillance Unit). A high incidence of cardiac involvement was found, with 18(40%) having proximal coronary artery dilatation or aneurysm. and 8(17.7%) with pericardial effusion detected by 2D Echocardiography during or shortly after the acute illness. One year after disease onset, persistent coronary artery changes were detectable by 2D Echocardiography in 53% of those initially affected. There have been no deaths and no patient has so far developed myocardial infarction. One patient has required coronary artery bypass grafting. A protocol for the acute management and long term follow-up of Kawasaki Disease is suggested.

引用

页码：397 / 400

页数：4

共 15 条

[1]

Kawasaki T., Acute febrile mucocutaneous lymph node syndrome: clinical observations of fifty cases, Japanese Journal of Allergy, 16, pp. 178-222, (1967)

[2]

Kato H., Koike S., Tanake C., Coronary heart disease in children with Kawasaki Syndrome, Jpn. Circ. J., 43, pp. 469-475, (1979)

[3]

Suzuki A., Kamiyya T., Ono Y., Kohahu T., Kimura K., Takamiyu M., Follow up study of coronary artery lesions due to Kawasaki disease by serial coronary arteriography in 200 patients, Heart Vessels, 3, pp. 159-165, (1987)

[4]

Kato H., Ichinose E., Kawasaki T., Myocardial Infarction in Kawasaki disease: Clinical analyses in 195 cases, Journ. Paed., 108, (1986)

[5]

Sulman S.T., Bass J.I., Bierman F., Burns J.C., Chung K., Dillon M.J., Et al., Management of Kawasaki Syndrome

[6]

a consensus statement prepared by North American participants of The Third International Kawasaki Disease Symposium, Tokyo, Japan, December, 1988 Paed. Infect. Dis. J., 8, pp. 663-667, (1989)

[7]

Tizard E.J., Suzuki A., Levin M., Dillon M.J., Clinical aspects of 100 patients with Kawasaki disease, Arch Dis. Child, 66, pp. 185-188, (1990)

[8]

Melish M.D., Kawasaki Syndrome (The Mucocutaneous Lymph Node Syndrome) Ann, Rev. Med., 33, pp. 569-585, (1982)

[9]

Rowley A.H., Gonzalez-Crussif, Kawasaki syndrome, Rev. Infect. Dis., 10, pp. 1-15, (1988)

[10]

Suzuki A., Tizard E.J., Gooch V., Dillon M.J., Howarth S.G., Kawasaki Disease: Echocardiographic features in 91 cases presenting in the United Kingdom, Arch Dis. Child., 65, pp. 1142-1146, (1990)

← 1 2 →